Name: Treating Patients With MS During the COVID-19 Pandemic
Uploaded: 2020-05-22T13:00:06Z
Description: Treating Patients With MS During the COVID-19 Pandemic

Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

The study added to the evidence base for recommending adherence to treatment with disease-modifying therapies in clinical practice, a key element for reducing moderate or severe relapse rate.

Adherence to Multiple Sclerosis Disease-Modifying Therapy Lowers Risk of Relapse, Severe Relapse

With the first approved biosimilar entering the US treatment market, the time for clinicians to understand the coming era of therapies is now.

Acceptance of and Access to Biosimilars and Generics: The MS Treatment Landscape and Patient Engagement

Videos

Neurology News Network for the week ending November 25, 2023. [WATCH TIME: 4 minutes

FDA Grants BrainStorm Meeting for NurOwn, Gene Therapy Study of AB-1005 Underway, VISION Trial to Test DBS Enhancement in PD

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 24, 2023.

NeurologyLive® Friday 5 — November 24, 2023

Pharmacist and Director of Clinical Content and Resources on the Clinical Innovation and Strategy team at the National Multiple Sclerosis Society

Rebecca Whitney, associate director of Programs and Community Support at SRNA and mother of child with a rare neuroimmune disorder, provided thoughts on the importance of caregivers and the role they play in everyday life.

The Label of ‘Caregiver’

Associate professor of clinical neurology at University of Miami Miller School of Medicine.

The associate professor of clinical neurology at University of Miami Miller School of Medicine discussed the implications of findings from a recent post hoc analysis on midazolam and the need for inclusive research in assessing the efficacy of seizure rescue treatments. [WATCH TIME: 3 minutes] 

The Practical Impact of Seizure Rescue Medication in the Landscape of Epilepsy Care: Kamil Detyniecki, MD

, has been with the team since October 2019. Follow him on Twitter 

The physician neurologist and neuroimmunologist at Cedars Sinai Medical Center discussed RNDS 2023, an educational event for Spanish-speaking patients with rare neuroimmune disorders.

NeuroVoices: Paula Barreras, MD, PhD, on the 2023 Spanish RNDS Hosted by SRNA

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

NMOSD

Narcolepsy

Ataxia

Parkinson Disease

AANEM 2023

CTAD 2023

MSMilan 2023

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Multiple Sclerosis and Risk of COVID-19

Disease-Modifying Therapies for MS During COVID-19

AAN 2020: Real-World Data on Cladribine Tablets for MS

Multiple Sclerosis: Takeaways From AAN 2020

MS Treatment Optimization During COVID-19